The Pharmaceutical Research and Manufacturers of America gained five new members last Friday.
Three biopharmaceutical research companies joined the association as members, while two others transitioned from research associates to full members.
Among the new affiliates is Teva Pharmaceutical Industries. The Israel-based drug company — a generic rival to a majority of the companies that form PhRMA — surprised the pharmaceutical industry when it requested to join the association earlier this month.
The four other new initiates are New Haven, Conn.-based Alexion Pharmaceuticals, Palo Alto, Calif.-based Jazz Pharmaceuticals, Waltham, Mass.-based AMAG Pharmaceuticals, and Lake Forest, Ill.-based Horizon Pharma.
The new members will aid in PhRMA's efforts to advocate for policy solutions to deliver innovative treatments to patients, modernize the drug development process, promote value-driven healthcare, engage consumers and address market distortions.
More articles on supply chain:
Prince Harry teams up with biotech to raise HIV awareness
CMS, FDA advocate device ID numbers in medical bills and claims
Drugmakers have firm grasp on drug pricing power